Robert T. Davis III

Robert T. Davis III is an accomplished Senior Research Scientist and Study Director at Virscio, where responsibilities include managing GLP and non-GLP studies and contributing to internal research in cardiovascular, metabolic, and respiratory diseases since January 2021. Prior experience includes serving as a Study Director at Covance, overseeing client-sponsored studies and ensuring compliance with regulatory requirements from June 2018 to January 2021, and as a Senior Scientist at Pfizer from July 2016 to June 2018, where focus was on drug target validation and assay development. Earlier roles include a Postdoctoral Research Fellow at the University of Illinois at Chicago, developing in-vivo and in-vitro models for studying cardiovascular physiology, and a PhD candidacy at the University of Florida, which established a strong foundational expertise in the field.